Allurion Technologies Files IPO Amendment

TL;DR

Allurion IPO filing updated. Looks like they're still aiming to go public.

AI Summary

Allurion Technologies, Inc. filed an S-1/A amendment on October 3, 2024, for its initial public offering. The company, previously known as Allurion Technologies Holdings, Inc. until February 7, 2023, is seeking to register its securities. The filing provides updated information for its IPO, with its principal executive offices located at 11 Huron Drive, Natick, MA 01760.

Why It Matters

This filing indicates Allurion Technologies is moving forward with its plan to become a publicly traded company, which could provide it with capital for growth and increase its visibility in the medical device market.

Risk Assessment

Risk Level: medium — As a company pursuing an IPO, there are inherent risks related to market conditions, regulatory approvals, and the company's ability to execute its business plan successfully.

Key Numbers

• 333-279902 — SEC File Number (Identifies the specific registration statement with the SEC.)

Key Players & Entities

• Allurion Technologies, Inc. (company) — Registrant
• October 3, 2024 (date) — Filing date
• 333-279902 (registration_number) — SEC Registration Number
• 11 Huron Drive Natick, MA 01760 (address) — Principal executive offices
• Shantanu Gaur (person) — Chief Executive Officer
• Allurion Technologies Holdings, Inc. (company) — Former company name
• February 7, 2023 (date) — Date of name change

FAQ

Key Financial Figures

• $48.0 million — Purchase Agreement, we issued and sold $48.0 million aggregate principal amount of convertib
• $1,000 — of 617.2840 shares of common stock per $1,000 principal amount of Notes (equivalent t
• $1.62 — to a conversion price of approximately $1.62 per share, which represents at 35% prem
• $2.7 m — gregate purchase price of approximately $2.7 million, at a purchase price of $1.20 per
• $1.20 — ly $2.7 million, at a purchase price of $1.20 per share of Series A Preferred Stock a

Filing Documents

• d837986ds1a.htm (S-1/A) — 123KB
• d837986dex51.htm (EX-5.1) — 9KB
• g837986g1003082309041.jpg (GRAPHIC) — 3KB
• 0001193125-24-231731.txt ( ) — 290KB
• alur-20240831.xsd (EX-101.SCH) — 4KB
• alur-20240831_cal.xml (EX-101.CAL) — 1KB
• alur-20240831_def.xml (EX-101.DEF) — 12KB
• alur-20240831_lab.xml (EX-101.LAB) — 18KB
• alur-20240831_pre.xml (EX-101.PRE) — 12KB
• d837986ds1a_htm.xml (XML) — 5KB

From the Filing

S-1/A As filed with the Securities and Exchange Commission on October 3, 2024 Registration No. 333-279902 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 2 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ALLURION TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Delaware 3841 92-2182207 (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identification No.) 11 Huron Drive Natick , MA 01760 ( 508 ) 647-4000 (Address, including zip code, and telephone number, including area code, of registrant's principal executive offices) Shantanu Gaur Chief Executive Officer Allurion Technologies, Inc. 11 Huron Drive Natick , MA 01760 Telephone: ( 508 ) 647-4000 (Name, address, including zip code, and telephone number, including area code, of agent for service) Copies to: Danielle M. Lauzon Jeffrey A. Letalien Paul R. Rosie Goodwin Procter LLP 100 Northern Avenue Boston, MA 02210 (617) 570-1000 Approximate date of commencement of proposed sale to the public : From time to time after this Registration Statement becomes effective. If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933 check the following box: If this form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. If this form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. If this form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act. Large accelerated filer Accelerated filer Non-accelerated Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. The registrant (the "Registrant") hereby amends this registration statement (this "Registration Statement") on such date or dates as may be necessary to delay its effective date until the Registrant shall file a further amendment which specifically states that this Registration Statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933 or until this Registration Statement shall become effective on such date as the Securities and Exchange Commission, acting pursuant to said Section 8(a), may determine. Allurion Technologies, Inc. is filing this Amendment No. 2 (this "Amendment") to its registration statement on Form S-1 (File No. 333-279902) (as amended, the "Registration Statement") as an exhibit-only filing. Accordingly, this Amendment consists only of the facing page, this explanatory note, Part II of the Registration Statement, the signature page to the Registration Statement and the filed exhibit. The remainder of the Registration Statement is unchanged and has therefore been omitted. PART II INFORMATION NOT REQUIRED IN PROSPECTUS Item13. Other Expenses of Issuance and Distribution. The following table sets forth the estimated expenses to be borne by the registrant in connection with the securities being registered hereby. Expense Estimated Amount Securities and Exchange Commission registration fee $ 10,349.09 Accounting fees and expenses * Legal fees and expenses * Financial printing and miscellaneous expenses * Total $ * * These fees are calculated based on the securities offered and the number of issuances and accordingly cannot be defined at this time. Item14. Indemnification of Directors and Officers Section 145(a) of the DGCL provides, in general, that a corporation may indemnify any person who was or is a party to or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative (other than an action by or in the right of the corporation), because he or she is or

View Full Filing

View this S-1/A filing on SEC EDGAR